

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 8.93017319 |
| 2 | muscle filament sliding (GO:0030049) | 8.54467423 |
| 3 | actin-myosin filament sliding (GO:0033275) | 8.54467423 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 7.84615523 |
| 5 | myofibril assembly (GO:0030239) | 7.54814829 |
| 6 | cardiac myofibril assembly (GO:0055003) | 7.54358332 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.47099006 |
| 8 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.19197520 |
| 9 | actin-mediated cell contraction (GO:0070252) | 7.06360005 |
| 10 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.87064049 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.80523953 |
| 12 | plasma membrane repair (GO:0001778) | 6.54348196 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.32404044 |
| 14 | cardiac muscle contraction (GO:0060048) | 6.26972718 |
| 15 | tricarboxylic acid cycle (GO:0006099) | 6.22786726 |
| 16 | carnitine shuttle (GO:0006853) | 6.04356838 |
| 17 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.97832834 |
| 18 | regulation of relaxation of muscle (GO:1901077) | 5.86780853 |
| 19 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.82678621 |
| 20 | striated muscle contraction (GO:0006941) | 5.82265896 |
| 21 | regulation of actin filament-based movement (GO:1903115) | 5.71334792 |
| 22 | cardiac muscle cell development (GO:0055013) | 5.69972853 |
| 23 | actomyosin structure organization (GO:0031032) | 5.67235366 |
| 24 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.64215427 |
| 25 | skeletal muscle contraction (GO:0003009) | 5.55501099 |
| 26 | regulation of cell communication by electrical coupling (GO:0010649) | 5.49969511 |
| 27 | cardiac cell development (GO:0055006) | 5.34005921 |
| 28 | actin filament-based movement (GO:0030048) | 5.30667580 |
| 29 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.29569868 |
| 30 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 5.29112576 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 5.26007382 |
| 32 | fatty acid transmembrane transport (GO:1902001) | 5.25258801 |
| 33 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.10124608 |
| 34 | skeletal muscle adaptation (GO:0043501) | 5.01445203 |
| 35 | cardiac muscle hypertrophy (GO:0003300) | 5.01273382 |
| 36 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.96074480 |
| 37 | creatine metabolic process (GO:0006600) | 4.96045436 |
| 38 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.88780294 |
| 39 | striated muscle hypertrophy (GO:0014897) | 4.86373538 |
| 40 | regulation of coenzyme metabolic process (GO:0051196) | 4.80694491 |
| 41 | regulation of cofactor metabolic process (GO:0051193) | 4.80694491 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 4.73438036 |
| 43 | heart process (GO:0003015) | 4.73177710 |
| 44 | heart contraction (GO:0060047) | 4.73177710 |
| 45 | adult heart development (GO:0007512) | 4.72315053 |
| 46 | regulation of sarcomere organization (GO:0060297) | 4.59329042 |
| 47 | muscle tissue morphogenesis (GO:0060415) | 4.59223752 |
| 48 | carnitine transmembrane transport (GO:1902603) | 4.55532754 |
| 49 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.55071133 |
| 50 | skeletal muscle fiber development (GO:0048741) | 4.54521585 |
| 51 | myotube cell development (GO:0014904) | 4.39134005 |
| 52 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.37682616 |
| 53 | muscle hypertrophy (GO:0014896) | 4.30477998 |
| 54 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.29999478 |
| 55 | amino-acid betaine transport (GO:0015838) | 4.27681347 |
| 56 | carnitine transport (GO:0015879) | 4.27681347 |
| 57 | regulation of membrane repolarization (GO:0060306) | 4.25448718 |
| 58 | heart trabecula formation (GO:0060347) | 4.21464841 |
| 59 | response to inactivity (GO:0014854) | 4.19209040 |
| 60 | muscle contraction (GO:0006936) | 4.17761714 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 4.14003146 |
| 62 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.04270104 |
| 63 | striated muscle adaptation (GO:0014888) | 3.98637923 |
| 64 | glycogen catabolic process (GO:0005980) | 3.96232670 |
| 65 | NADH metabolic process (GO:0006734) | 3.95518342 |
| 66 | skeletal muscle tissue development (GO:0007519) | 3.93575096 |
| 67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.93149320 |
| 68 | regulation of sulfur metabolic process (GO:0042762) | 3.92948423 |
| 69 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.89128969 |
| 70 | cell communication involved in cardiac conduction (GO:0086065) | 3.87780158 |
| 71 | muscle system process (GO:0003012) | 3.85902894 |
| 72 | muscle cell cellular homeostasis (GO:0046716) | 3.81829203 |
| 73 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.81828976 |
| 74 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.81828976 |
| 75 | striated muscle atrophy (GO:0014891) | 3.80982335 |
| 76 | striated muscle cell development (GO:0055002) | 3.77522895 |
| 77 | regulation of sequestering of triglyceride (GO:0010889) | 3.77206692 |
| 78 | relaxation of cardiac muscle (GO:0055119) | 3.76993829 |
| 79 | regulation of the force of heart contraction (GO:0002026) | 3.76339084 |
| 80 | response to muscle activity (GO:0014850) | 3.74436811 |
| 81 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.70974745 |
| 82 | glucan catabolic process (GO:0009251) | 3.69870846 |
| 83 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.65636351 |
| 84 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.64309541 |
| 85 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.64053992 |
| 86 | response to caffeine (GO:0031000) | 3.60437272 |
| 87 | oxidative phosphorylation (GO:0006119) | 3.59711193 |
| 88 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.58071977 |
| 89 | muscle hypertrophy in response to stress (GO:0003299) | 3.58071977 |
| 90 | cardiac muscle adaptation (GO:0014887) | 3.58071977 |
| 91 | respiratory electron transport chain (GO:0022904) | 3.57442248 |
| 92 | relaxation of muscle (GO:0090075) | 3.54872478 |
| 93 | cardiac muscle cell action potential (GO:0086001) | 3.54600604 |
| 94 | regulation of cardiac muscle contraction (GO:0055117) | 3.54330734 |
| 95 | positive regulation of cation channel activity (GO:2001259) | 3.54134177 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.53898489 |
| 97 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.53898489 |
| 98 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.51796525 |
| 99 | muscle adaptation (GO:0043500) | 3.51327864 |
| 100 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.50700351 |
| 101 | regulation of muscle system process (GO:0090257) | 3.49251921 |
| 102 | aspartate family amino acid catabolic process (GO:0009068) | 3.48417091 |
| 103 | regulation of ATP catabolic process (GO:1903289) | 3.47690900 |
| 104 | regulation of ATPase activity (GO:0043462) | 3.47690900 |
| 105 | muscle fiber development (GO:0048747) | 3.47550959 |
| 106 | regulation of muscle contraction (GO:0006937) | 3.46448683 |
| 107 | electron transport chain (GO:0022900) | 3.45934173 |
| 108 | cellular polysaccharide catabolic process (GO:0044247) | 3.45703169 |
| 109 | negative regulation of potassium ion transport (GO:0043267) | 3.42347149 |
| 110 | lysine catabolic process (GO:0006554) | 3.39396323 |
| 111 | lysine metabolic process (GO:0006553) | 3.39396323 |
| 112 | regulation of heart rate (GO:0002027) | 3.38873671 |
| 113 | skeletal muscle tissue regeneration (GO:0043403) | 3.36816943 |
| 114 | glycogen biosynthetic process (GO:0005978) | 3.36116631 |
| 115 | glucan biosynthetic process (GO:0009250) | 3.36116631 |
| 116 | polysaccharide catabolic process (GO:0000272) | 3.34656188 |
| 117 | ATP synthesis coupled proton transport (GO:0015986) | 3.34168616 |
| 118 | muscle structure development (GO:0061061) | 3.29831575 |
| 119 | muscle cell development (GO:0055001) | 3.27697519 |
| 120 | muscle organ development (GO:0007517) | 3.27102344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.50650624 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.26097332 |
| 3 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 4.20287795 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.13897574 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.97712864 |
| 6 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.92913147 |
| 7 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.92913147 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.60802382 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.34292723 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.99227599 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.96634112 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.87993367 |
| 13 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.81742780 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.66871970 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.63764621 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.45421768 |
| 17 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.30761488 |
| 18 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.24497814 |
| 19 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.23830806 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.23786645 |
| 21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.21045754 |
| 22 | VDR_22108803_ChIP-Seq_LS180_Human | 2.18298171 |
| 23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.95830585 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.87389195 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.77109677 |
| 26 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74750573 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.67611992 |
| 28 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.66665464 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.63024953 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.61847996 |
| 31 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.60791957 |
| 32 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.60098997 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.58366229 |
| 34 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.58083006 |
| 35 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.55587587 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.53940152 |
| 37 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52106805 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.49207258 |
| 39 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.47244211 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.45615370 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45201106 |
| 42 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.42527754 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.40044597 |
| 44 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.33068987 |
| 45 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.32065142 |
| 46 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30934638 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.30127703 |
| 48 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.28698626 |
| 49 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.27097067 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.26231988 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25227908 |
| 52 | GATA1_22025678_ChIP-Seq_K562_Human | 1.23418064 |
| 53 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.22403138 |
| 54 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.21983003 |
| 55 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21923814 |
| 56 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21728475 |
| 57 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20856801 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.20328895 |
| 59 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19397191 |
| 60 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17876548 |
| 61 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.17223069 |
| 62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.16411739 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.14680496 |
| 64 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11746026 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.11604307 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.09544005 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09026045 |
| 68 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08916589 |
| 69 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.08754582 |
| 70 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.08591424 |
| 71 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.07784043 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06966425 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06966425 |
| 74 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.06145363 |
| 75 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05653146 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.02823830 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.02799203 |
| 78 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.02451296 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.01919134 |
| 80 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.01729903 |
| 81 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.00818920 |
| 82 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.00818920 |
| 83 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.00694001 |
| 84 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.00060993 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99951167 |
| 86 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99889749 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99651703 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98754612 |
| 89 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.98575398 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98456334 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98024436 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97403542 |
| 93 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.97178826 |
| 94 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96186237 |
| 95 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96082981 |
| 96 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.95192563 |
| 97 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94874243 |
| 98 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94081850 |
| 99 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.93852045 |
| 100 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.93536596 |
| 101 | P68_20966046_ChIP-Seq_HELA_Human | 0.93171764 |
| 102 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.93048673 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91473520 |
| 104 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.91449022 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91065350 |
| 106 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90977020 |
| 107 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89881012 |
| 108 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.89878410 |
| 109 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89497630 |
| 110 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.89208872 |
| 111 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.88633604 |
| 112 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87564224 |
| 113 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.87274733 |
| 114 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87000649 |
| 115 | CJUN_26792858_Chip-Seq_BT549_Human | 0.86605296 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 0.86358354 |
| 117 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86275117 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.86267846 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85877547 |
| 120 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.85620558 |
| 121 | TBL1_22424771_ChIP-Seq_293T_Human | 0.85226320 |
| 122 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.84542291 |
| 123 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83911828 |
| 124 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83531488 |
| 125 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.83060647 |
| 126 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.82926418 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82698185 |
| 128 | NFYB_21822215_ChIP-Seq_K562_Human | 0.82697373 |
| 129 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82691602 |
| 130 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82691602 |
| 131 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82293070 |
| 132 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81992712 |
| 133 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.81831707 |
| 134 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.81819103 |
| 135 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.80514978 |
| 136 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80132349 |
| 137 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.79794581 |
| 138 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.79541621 |
| 139 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79287289 |
| 140 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.79067791 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78860779 |
| 142 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.78769827 |
| 143 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78666269 |
| 144 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.78651451 |
| 145 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.77286586 |
| 146 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77262620 |
| 147 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.76924112 |
| 148 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.76646402 |
| 149 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.76048806 |
| 150 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.75803254 |
| 151 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.75773881 |
| 152 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.74958838 |
| 153 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.74324871 |
| 154 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.74021354 |
| 155 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.73126433 |
| 156 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.73036934 |
| 157 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72633769 |
| 158 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.72394912 |
| 159 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.72233119 |
| 160 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.72122720 |
| 161 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72024728 |
| 162 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.71036518 |
| 163 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.70760058 |
| 164 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.70635978 |
| 165 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.70066479 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.42437367 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.36322310 |
| 3 | MP0000751_myopathy | 5.45842795 |
| 4 | MP0004084_abnormal_cardiac_muscle | 4.82073951 |
| 5 | MP0000749_muscle_degeneration | 4.69470688 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.34346034 |
| 7 | MP0004215_abnormal_myocardial_fiber | 4.11215935 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 3.97103690 |
| 9 | MP0005330_cardiomyopathy | 3.53927314 |
| 10 | MP0004087_abnormal_muscle_fiber | 3.32208072 |
| 11 | MP0002106_abnormal_muscle_physiology | 3.10082114 |
| 12 | MP0004130_abnormal_muscle_cell | 2.98525662 |
| 13 | MP0000750_abnormal_muscle_regeneration | 2.96961722 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.92113348 |
| 15 | MP0002269_muscular_atrophy | 2.79920046 |
| 16 | MP0000747_muscle_weakness | 2.76470653 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.74567012 |
| 18 | MP0005369_muscle_phenotype | 2.53447415 |
| 19 | MP0000759_abnormal_skeletal_muscle | 2.53346985 |
| 20 | MP0008775_abnormal_heart_ventricle | 2.43897630 |
| 21 | MP0003137_abnormal_impulse_conducting | 2.40109684 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.33909422 |
| 23 | MP0004484_altered_response_of | 2.30803996 |
| 24 | MP0005385_cardiovascular_system_phenoty | 2.25435658 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.25435658 |
| 26 | MP0004233_abnormal_muscle_weight | 2.01430454 |
| 27 | MP0003221_abnormal_cardiomyocyte_apopto | 1.95901588 |
| 28 | MP0006036_abnormal_mitochondrial_physio | 1.92510221 |
| 29 | MP0006138_congestive_heart_failure | 1.89090122 |
| 30 | MP0004510_myositis | 1.76922305 |
| 31 | MP0003828_pulmonary_edema | 1.70372102 |
| 32 | MP0002332_abnormal_exercise_endurance | 1.68012639 |
| 33 | MP0004085_abnormal_heartbeat | 1.66166906 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.56238141 |
| 35 | MP0002127_abnormal_cardiovascular_syste | 1.41955417 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.39417253 |
| 37 | MP0005670_abnormal_white_adipose | 1.28593362 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.26214432 |
| 39 | MP0002108_abnormal_muscle_morphology | 1.21473065 |
| 40 | MP0001661_extended_life_span | 1.19573709 |
| 41 | MP0006035_abnormal_mitochondrial_morpho | 1.12588591 |
| 42 | MP0000733_abnormal_muscle_development | 1.10060881 |
| 43 | MP0000343_altered_response_to | 1.08246005 |
| 44 | MP0005375_adipose_tissue_phenotype | 1.06662904 |
| 45 | MP0004270_analgesia | 1.06423423 |
| 46 | MP0000266_abnormal_heart_morphology | 1.00756645 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.00070840 |
| 48 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96752818 |
| 49 | MP0005266_abnormal_metabolism | 0.93393123 |
| 50 | MP0002234_abnormal_pharynx_morphology | 0.91324139 |
| 51 | MP0005165_increased_susceptibility_to | 0.87684555 |
| 52 | MP0004043_abnormal_pH_regulation | 0.84491601 |
| 53 | MP0002971_abnormal_brown_adipose | 0.83747042 |
| 54 | MP0010368_abnormal_lymphatic_system | 0.78751264 |
| 55 | MP0000372_irregular_coat_pigmentation | 0.77667830 |
| 56 | MP0000230_abnormal_systemic_arterial | 0.72068810 |
| 57 | MP0000013_abnormal_adipose_tissue | 0.71354883 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 0.70975320 |
| 59 | MP0003279_aneurysm | 0.67024246 |
| 60 | MP0002128_abnormal_blood_circulation | 0.65931636 |
| 61 | MP0004147_increased_porphyrin_level | 0.63696320 |
| 62 | MP0002638_abnormal_pupillary_reflex | 0.63532894 |
| 63 | MP0005451_abnormal_body_composition | 0.62109069 |
| 64 | MP0000003_abnormal_adipose_tissue | 0.60157714 |
| 65 | MP0002078_abnormal_glucose_homeostasis | 0.57332202 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 0.56096195 |
| 67 | MP0005167_abnormal_blood-brain_barrier | 0.55621347 |
| 68 | MP0008961_abnormal_basal_metabolism | 0.54838042 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.49896312 |
| 70 | MP0004142_abnormal_muscle_tone | 0.49082356 |
| 71 | MP0008569_lethality_at_weaning | 0.48661375 |
| 72 | MP0001879_abnormal_lymphatic_vessel | 0.45303588 |
| 73 | MP0003195_calcinosis | 0.45266966 |
| 74 | MP0002909_abnormal_adrenal_gland | 0.44169551 |
| 75 | MP0001984_abnormal_olfaction | 0.43766689 |
| 76 | MP0005334_abnormal_fat_pad | 0.42412967 |
| 77 | MP0000767_abnormal_smooth_muscle | 0.42073986 |
| 78 | MP0005187_abnormal_penis_morphology | 0.41984978 |
| 79 | MP0005623_abnormal_meninges_morphology | 0.38444024 |
| 80 | MP0005535_abnormal_body_temperature | 0.38217418 |
| 81 | MP0003045_fibrosis | 0.37942415 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.37673631 |
| 83 | MP0005083_abnormal_biliary_tract | 0.37624958 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.36747653 |
| 85 | MP0004924_abnormal_behavior | 0.36747653 |
| 86 | MP0004134_abnormal_chest_morphology | 0.35540630 |
| 87 | MP0003879_abnormal_hair_cell | 0.35095223 |
| 88 | MP0003656_abnormal_erythrocyte_physiolo | 0.34923688 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.34642430 |
| 90 | MP0005275_abnormal_skin_tensile | 0.34076214 |
| 91 | MP0005332_abnormal_amino_acid | 0.33180207 |
| 92 | MP0009840_abnormal_foam_cell | 0.32211788 |
| 93 | MP0002925_abnormal_cardiovascular_devel | 0.31874693 |
| 94 | MP0005085_abnormal_gallbladder_physiolo | 0.29404835 |
| 95 | MP0009115_abnormal_fat_cell | 0.28882621 |
| 96 | MP0006276_abnormal_autonomic_nervous | 0.28184757 |
| 97 | MP0003948_abnormal_gas_homeostasis | 0.27968323 |
| 98 | MP0005423_abnormal_somatic_nervous | 0.26252958 |
| 99 | MP0001614_abnormal_blood_vessel | 0.26058436 |
| 100 | MP0008438_abnormal_cutaneous_collagen | 0.25319464 |
| 101 | MP0005452_abnormal_adipose_tissue | 0.24663712 |
| 102 | MP0001784_abnormal_fluid_regulation | 0.24194437 |
| 103 | MP0002066_abnormal_motor_capabilities/c | 0.22447886 |
| 104 | MP0001853_heart_inflammation | 0.22190046 |
| 105 | MP0003984_embryonic_growth_retardation | 0.22175295 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.21711425 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.21470367 |
| 108 | MP0002088_abnormal_embryonic_growth/wei | 0.21115374 |
| 109 | MP0001765_abnormal_ion_homeostasis | 0.20990737 |
| 110 | MP0003136_yellow_coat_color | 0.20924524 |
| 111 | MP0002822_catalepsy | 0.19482660 |
| 112 | MP0001299_abnormal_eye_distance/ | 0.18586017 |
| 113 | MP0002067_abnormal_sensory_capabilities | 0.18534964 |
| 114 | MP0001727_abnormal_embryo_implantation | 0.18529809 |
| 115 | MP0002272_abnormal_nervous_system | 0.18497348 |
| 116 | MP0002734_abnormal_mechanical_nocicepti | 0.18161381 |
| 117 | MP0009384_cardiac_valve_regurgitation | 0.18079501 |
| 118 | MP0001529_abnormal_vocalization | 0.17089155 |
| 119 | MP0002970_abnormal_white_adipose | 0.17024947 |
| 120 | MP0000579_abnormal_nail_morphology | 0.16919474 |
| 121 | MP0009780_abnormal_chondrocyte_physiolo | 0.16869335 |
| 122 | MP0009672_abnormal_birth_weight | 0.15808846 |
| 123 | MP0005166_decreased_susceptibility_to | 0.15291290 |
| 124 | MP0002114_abnormal_axial_skeleton | 0.15030981 |
| 125 | MP0001486_abnormal_startle_reflex | 0.14765363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.35186939 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.09762308 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.89946480 |
| 4 | Sudden death (HP:0001699) | 6.86185494 |
| 5 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.82096880 |
| 6 | Muscle fiber splitting (HP:0003555) | 6.17689641 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.75177334 |
| 8 | Myoglobinuria (HP:0002913) | 5.54985522 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 5.46124758 |
| 10 | Muscle fiber inclusion bodies (HP:0100299) | 5.41439322 |
| 11 | Abnormality of the calf musculature (HP:0001430) | 5.29650922 |
| 12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.24568895 |
| 13 | Subaortic stenosis (HP:0001682) | 4.69864107 |
| 14 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.69864107 |
| 15 | Atrial fibrillation (HP:0005110) | 4.68638172 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 4.65537375 |
| 17 | Difficulty running (HP:0009046) | 4.55144179 |
| 18 | Nemaline bodies (HP:0003798) | 4.51024063 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.42192140 |
| 20 | Lipoatrophy (HP:0100578) | 4.41311070 |
| 21 | Increased connective tissue (HP:0009025) | 4.40686303 |
| 22 | Primary atrial arrhythmia (HP:0001692) | 4.37223018 |
| 23 | Type 1 muscle fiber predominance (HP:0003803) | 4.29592097 |
| 24 | Supraventricular tachycardia (HP:0004755) | 4.21930860 |
| 25 | Supraventricular arrhythmia (HP:0005115) | 4.12571134 |
| 26 | Right ventricular cardiomyopathy (HP:0011663) | 4.06250814 |
| 27 | Myotonia (HP:0002486) | 3.91531823 |
| 28 | Asymmetric septal hypertrophy (HP:0001670) | 3.87970206 |
| 29 | Bundle branch block (HP:0011710) | 3.87007042 |
| 30 | Dilated cardiomyopathy (HP:0001644) | 3.79279806 |
| 31 | Syncope (HP:0001279) | 3.70167991 |
| 32 | Palpitations (HP:0001962) | 3.59725730 |
| 33 | Muscle stiffness (HP:0003552) | 3.57765481 |
| 34 | Prolonged QT interval (HP:0001657) | 3.32850193 |
| 35 | Difficulty climbing stairs (HP:0003551) | 3.32456687 |
| 36 | Ventricular arrhythmia (HP:0004308) | 3.26310564 |
| 37 | Distal arthrogryposis (HP:0005684) | 3.23290116 |
| 38 | Heart block (HP:0012722) | 3.20793707 |
| 39 | Myopathic facies (HP:0002058) | 3.15884377 |
| 40 | Round ear (HP:0100830) | 3.03250276 |
| 41 | Abnormal atrioventricular conduction (HP:0005150) | 3.02148307 |
| 42 | Areflexia of lower limbs (HP:0002522) | 3.00279342 |
| 43 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.98433362 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.98182068 |
| 45 | Atrioventricular block (HP:0001678) | 2.95835774 |
| 46 | Neck muscle weakness (HP:0000467) | 2.91820385 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.89631551 |
| 48 | Rimmed vacuoles (HP:0003805) | 2.81711770 |
| 49 | Ventricular fibrillation (HP:0001663) | 2.73483899 |
| 50 | Ulnar deviation of the wrist (HP:0003049) | 2.61683961 |
| 51 | Ketoacidosis (HP:0001993) | 2.61579741 |
| 52 | Abnormal finger flexion creases (HP:0006143) | 2.46122926 |
| 53 | Limb-girdle muscle atrophy (HP:0003797) | 2.45051299 |
| 54 | Left ventricular hypertrophy (HP:0001712) | 2.42492764 |
| 55 | Hepatic necrosis (HP:0002605) | 2.42134723 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.40786872 |
| 57 | Bulbar palsy (HP:0001283) | 2.40563197 |
| 58 | Abnormal EKG (HP:0003115) | 2.38566377 |
| 59 | Malignant hyperthermia (HP:0002047) | 2.36352062 |
| 60 | Hypoplastic ischia (HP:0003175) | 2.34615714 |
| 61 | Acute necrotizing encephalopathy (HP:0006965) | 2.33286366 |
| 62 | Muscular dystrophy (HP:0003560) | 2.31977640 |
| 63 | Ragged-red muscle fibers (HP:0003200) | 2.30410277 |
| 64 | EMG: neuropathic changes (HP:0003445) | 2.30117144 |
| 65 | Hypoglycemic coma (HP:0001325) | 2.23542919 |
| 66 | Generalized muscle weakness (HP:0003324) | 2.20038068 |
| 67 | Increased muscle lipid content (HP:0009058) | 2.15987658 |
| 68 | Palmoplantar keratoderma (HP:0000982) | 2.15426699 |
| 69 | Facial diplegia (HP:0001349) | 2.15153150 |
| 70 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.14712739 |
| 71 | Testicular atrophy (HP:0000029) | 2.14361650 |
| 72 | Weak cry (HP:0001612) | 2.13819887 |
| 73 | Distal lower limb amyotrophy (HP:0008944) | 2.12637811 |
| 74 | Frequent falls (HP:0002359) | 2.12494995 |
| 75 | Acute encephalopathy (HP:0006846) | 2.10369686 |
| 76 | Gowers sign (HP:0003391) | 2.10007758 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.09055206 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09055206 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.07196095 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.05679605 |
| 81 | Slender build (HP:0001533) | 2.05675628 |
| 82 | Ketosis (HP:0001946) | 2.04712221 |
| 83 | Abnormality of the ischium (HP:0003174) | 2.04480934 |
| 84 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.00575854 |
| 85 | Proximal amyotrophy (HP:0007126) | 2.00136884 |
| 86 | Calcaneovalgus deformity (HP:0001848) | 1.99122321 |
| 87 | Cerebral edema (HP:0002181) | 1.98340774 |
| 88 | Exercise intolerance (HP:0003546) | 1.97960533 |
| 89 | Waddling gait (HP:0002515) | 1.97253481 |
| 90 | Absent phalangeal crease (HP:0006109) | 1.95905840 |
| 91 | Abnormality of alanine metabolism (HP:0010916) | 1.95792910 |
| 92 | Hyperalaninemia (HP:0003348) | 1.95792910 |
| 93 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.95792910 |
| 94 | Fetal akinesia sequence (HP:0001989) | 1.95034231 |
| 95 | Scapular winging (HP:0003691) | 1.94918513 |
| 96 | Progressive muscle weakness (HP:0003323) | 1.94255753 |
| 97 | Progressive macrocephaly (HP:0004481) | 1.93877751 |
| 98 | Abnormality of the neuromuscular junction (HP:0003398) | 1.93035180 |
| 99 | Fatigable weakness (HP:0003473) | 1.93035180 |
| 100 | Conjunctival hamartoma (HP:0100780) | 1.92978137 |
| 101 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.91669208 |
| 102 | Abnormality of the foot musculature (HP:0001436) | 1.91472358 |
| 103 | Hip contracture (HP:0003273) | 1.91317154 |
| 104 | Foot dorsiflexor weakness (HP:0009027) | 1.89965372 |
| 105 | Spinal rigidity (HP:0003306) | 1.88328267 |
| 106 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88052042 |
| 107 | Mitochondrial inheritance (HP:0001427) | 1.87897256 |
| 108 | Lower limb amyotrophy (HP:0007210) | 1.85970084 |
| 109 | Limb-girdle muscle weakness (HP:0003325) | 1.83837154 |
| 110 | Increased CSF lactate (HP:0002490) | 1.82906914 |
| 111 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.81899545 |
| 112 | Deformed tarsal bones (HP:0008119) | 1.80533362 |
| 113 | Steppage gait (HP:0003376) | 1.79008129 |
| 114 | Hyperkalemia (HP:0002153) | 1.77978272 |
| 115 | Lactic acidosis (HP:0003128) | 1.77889412 |
| 116 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.77576371 |
| 117 | Oligomenorrhea (HP:0000876) | 1.69975891 |
| 118 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.63399711 |
| 119 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.63399711 |
| 120 | Toxemia of pregnancy (HP:0100603) | 1.51062003 |
| 121 | Shoulder girdle muscle weakness (HP:0003547) | 1.49961800 |
| 122 | Pelvic girdle muscle weakness (HP:0003749) | 1.49716809 |
| 123 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.46810123 |
| 124 | Abnormality of the calcaneus (HP:0008364) | 1.45925616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 6.37729290 |
| 2 | TTN | 6.31606258 |
| 3 | PHKG2 | 4.79778870 |
| 4 | PHKG1 | 4.79778870 |
| 5 | PDK4 | 3.27750131 |
| 6 | PDK3 | 3.27750131 |
| 7 | DMPK | 2.81378772 |
| 8 | LMTK2 | 2.73248592 |
| 9 | BCKDK | 2.52643603 |
| 10 | TRIB3 | 2.44271295 |
| 11 | NEK1 | 2.42865794 |
| 12 | MYLK | 2.36992658 |
| 13 | MUSK | 2.33329501 |
| 14 | PKN2 | 2.30080425 |
| 15 | PINK1 | 2.27032841 |
| 16 | PIK3CA | 2.12612263 |
| 17 | PDK2 | 2.01472340 |
| 18 | NME1 | 1.71104610 |
| 19 | MAP2K3 | 1.61328884 |
| 20 | STK24 | 1.54771424 |
| 21 | TIE1 | 1.53758643 |
| 22 | MAP3K7 | 1.53416029 |
| 23 | MARK1 | 1.37177861 |
| 24 | PIK3CG | 1.30515286 |
| 25 | MAPK12 | 1.25614063 |
| 26 | LIMK1 | 1.19357897 |
| 27 | GRK7 | 1.14221799 |
| 28 | ZAK | 1.01635813 |
| 29 | PRKAA2 | 1.00415296 |
| 30 | PRKAA1 | 0.99349605 |
| 31 | CAMK2D | 0.99107887 |
| 32 | PRKD1 | 0.99027888 |
| 33 | MAPKAPK3 | 0.94182911 |
| 34 | PAK3 | 0.92220148 |
| 35 | ILK | 0.87961645 |
| 36 | INSRR | 0.87384598 |
| 37 | TRPM7 | 0.83335217 |
| 38 | STK38L | 0.83067701 |
| 39 | WNK4 | 0.81286372 |
| 40 | MAP3K3 | 0.78389509 |
| 41 | CCNB1 | 0.77865400 |
| 42 | ERBB3 | 0.76242985 |
| 43 | ROCK1 | 0.75695780 |
| 44 | MAP3K5 | 0.73978472 |
| 45 | NEK9 | 0.73578264 |
| 46 | RIPK1 | 0.72791511 |
| 47 | PKN1 | 0.68892347 |
| 48 | MAP2K4 | 0.68514227 |
| 49 | FLT3 | 0.60430520 |
| 50 | EPHB1 | 0.60369988 |
| 51 | STK4 | 0.57961166 |
| 52 | CDC42BPA | 0.53716610 |
| 53 | STK38 | 0.52298570 |
| 54 | MAPK4 | 0.51951981 |
| 55 | CAMK2B | 0.51773767 |
| 56 | CAMK4 | 0.51374558 |
| 57 | MAP2K6 | 0.51077452 |
| 58 | FRK | 0.49610348 |
| 59 | WNK1 | 0.48821636 |
| 60 | AKT2 | 0.48572623 |
| 61 | MAP2K1 | 0.47240901 |
| 62 | PDGFRA | 0.46935995 |
| 63 | MOS | 0.46021532 |
| 64 | PRKACB | 0.44278441 |
| 65 | CAMK2G | 0.42304872 |
| 66 | TGFBR2 | 0.41330154 |
| 67 | LATS1 | 0.39719344 |
| 68 | CAMK2A | 0.39673261 |
| 69 | SIK1 | 0.38764643 |
| 70 | ROCK2 | 0.37906429 |
| 71 | SGK2 | 0.36320766 |
| 72 | EPHA3 | 0.36096325 |
| 73 | PRKACA | 0.34985622 |
| 74 | MAPK11 | 0.34674486 |
| 75 | DYRK1B | 0.34397663 |
| 76 | DAPK3 | 0.34231701 |
| 77 | PDPK1 | 0.33969722 |
| 78 | PTK6 | 0.33551986 |
| 79 | KDR | 0.33143769 |
| 80 | PRKACG | 0.31952200 |
| 81 | TAOK1 | 0.31193357 |
| 82 | RPS6KC1 | 0.30998470 |
| 83 | RPS6KL1 | 0.30998470 |
| 84 | MAPK13 | 0.30614257 |
| 85 | PDK1 | 0.28324588 |
| 86 | CAMK1 | 0.28286487 |
| 87 | PTK2B | 0.27838715 |
| 88 | LATS2 | 0.26309007 |
| 89 | STK11 | 0.26008474 |
| 90 | ICK | 0.25801957 |
| 91 | SGK1 | 0.25767115 |
| 92 | RPS6KA6 | 0.25063179 |
| 93 | SGK3 | 0.24182296 |
| 94 | DAPK2 | 0.23020993 |
| 95 | RPS6KA1 | 0.22528610 |
| 96 | MARK3 | 0.22462522 |
| 97 | KSR2 | 0.21741919 |
| 98 | PRKG1 | 0.21560776 |
| 99 | NLK | 0.21403503 |
| 100 | STK39 | 0.20774061 |
| 101 | MAP3K13 | 0.20767863 |
| 102 | RPS6KA3 | 0.18776085 |
| 103 | MAPK10 | 0.18770691 |
| 104 | MAP3K6 | 0.18500319 |
| 105 | MAP3K11 | 0.18108684 |
| 106 | PRKCH | 0.18006559 |
| 107 | MTOR | 0.17362783 |
| 108 | TNIK | 0.17322589 |
| 109 | JAK1 | 0.17165439 |
| 110 | PRKCE | 0.16631793 |
| 111 | RET | 0.15778877 |
| 112 | MAP3K4 | 0.15379083 |
| 113 | MAP3K1 | 0.15122457 |
| 114 | FGFR4 | 0.15085340 |
| 115 | ZAP70 | 0.15078013 |
| 116 | RPS6KB1 | 0.14734443 |
| 117 | MAPK7 | 0.14046819 |
| 118 | EEF2K | 0.13630106 |
| 119 | LRRK2 | 0.13254048 |
| 120 | SGK223 | 0.12727344 |
| 121 | SGK494 | 0.12727344 |
| 122 | TAOK2 | 0.10969548 |
| 123 | BLK | 0.10614776 |
| 124 | TBK1 | 0.10210941 |
| 125 | JAK2 | 0.10072538 |
| 126 | PRKD3 | 0.09893507 |
| 127 | CAMK1G | 0.09300153 |
| 128 | PAK6 | 0.09078977 |
| 129 | MARK2 | 0.05939664 |
| 130 | ADRBK1 | 0.04952171 |
| 131 | FGFR3 | 0.04839950 |
| 132 | PRKCA | 0.04616692 |
| 133 | MAPK9 | 0.04537705 |
| 134 | PRKCQ | 0.02549214 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.67359504 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.26739380 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.96054721 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.73484224 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.59670328 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.40852725 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.40633061 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.88467309 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.68450856 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.67664283 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.56567844 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.52140533 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47553441 |
| 14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.16813060 |
| 15 | Alzheimers disease_Homo sapiens_hsa05010 | 2.03827717 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96237222 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.94286489 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.66186439 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.63886778 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60292532 |
| 21 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.60134599 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.56680016 |
| 23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55106001 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.45834224 |
| 25 | Insulin resistance_Homo sapiens_hsa04931 | 1.34598408 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.31293725 |
| 27 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.28849849 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.24960957 |
| 29 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.21075671 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.19263603 |
| 31 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.15305655 |
| 32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14484215 |
| 33 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99817041 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97280508 |
| 35 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95365551 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.94169551 |
| 37 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94059476 |
| 38 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.93451135 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90986793 |
| 40 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87005778 |
| 41 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.85731345 |
| 42 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.84573268 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 0.81764508 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 0.81046267 |
| 45 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79498619 |
| 46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.71328897 |
| 47 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.69477652 |
| 48 | Peroxisome_Homo sapiens_hsa04146 | 0.68732769 |
| 49 | Focal adhesion_Homo sapiens_hsa04510 | 0.66052679 |
| 50 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.64583807 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61380977 |
| 52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59607251 |
| 53 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.59042839 |
| 54 | Tight junction_Homo sapiens_hsa04530 | 0.54725878 |
| 55 | Salivary secretion_Homo sapiens_hsa04970 | 0.53917808 |
| 56 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53686010 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52805296 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52786613 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51342931 |
| 60 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50746229 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50651865 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.48504319 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.43821253 |
| 64 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.41617424 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.40350905 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37128361 |
| 67 | Renin secretion_Homo sapiens_hsa04924 | 0.37034133 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.35952822 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34530184 |
| 70 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33726030 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.31906300 |
| 72 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31301314 |
| 73 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30374784 |
| 74 | Insulin secretion_Homo sapiens_hsa04911 | 0.29617757 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.29167112 |
| 76 | GABAergic synapse_Homo sapiens_hsa04727 | 0.28604425 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.27908952 |
| 78 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.27198527 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.25683175 |
| 80 | Amoebiasis_Homo sapiens_hsa05146 | 0.25470821 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.25360254 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25127201 |
| 83 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.24602241 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24261892 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.22828269 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22309183 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.20864789 |
| 88 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19865083 |
| 89 | Phototransduction_Homo sapiens_hsa04744 | 0.19033225 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.18770688 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.18711063 |
| 92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17572293 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.17423253 |
| 94 | Platelet activation_Homo sapiens_hsa04611 | 0.16132844 |
| 95 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.15776867 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.15064054 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.14870070 |
| 98 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.14462056 |
| 99 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.14259114 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.13872296 |
| 101 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.12253289 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.11592380 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11345001 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11305841 |
| 105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.11193971 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.10696149 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10606459 |
| 108 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.10151554 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.08109993 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.07608267 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.04883789 |
| 112 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.02598811 |
| 113 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0483513 |
| 114 | Gap junction_Homo sapiens_hsa04540 | -0.0375074 |
| 115 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | -0.0363614 |
| 116 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | -0.0193186 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | -0.0081397 |
| 118 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | -0.0077385 |
| 119 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0076263 |

